2022 Annual Meeting of the NCI Cohort Consortium

Tue, 11/01/2022 - 12:00 - Wed, 11/02/2022 - 12:00

November 1 -2, 2022

Virtual

Overview

The 2022 Annual Meeting of the NCI Cohort Consortium was held virtually on November 1^st and November 2^nd. The meeting was sponsored by the Division of Cancer Control and Population Sciences (Epidemiology and Genomics Research Program) and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (NCI), with a goal to bring together consortium researchers to discuss emerging science, scientific progress of consortium projects and groups, gaps and opportunities for collaboration across studies, and ideas for new scientific projects in the consortium.

The main meeting was organized into two half-days on November 1^st, 8:00 AM - 11:45 AM (ET) and November 2^nd, 1:00 PM - 5:00 PM (ET). See the meeting Agenda for more details. There will also be Project group meetings held in September and October before the main meeting. See the meeting schedule under Project Group Meetings. 

Agenda

Download Agenda

Day 1, Tuesday, November 1, 2022 (8:00–11:45 a.m. ET)

8:00–8:40	Watch this Session Opening Remarks and Acknowledgements Dr. Kathy Helzlsouer, National Cancer Institute, NIH Dr. Heather Eliassen, Harvard Medical School and Harvard School of Public Health Welcoming Remarks from the National Cancer Institute Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH Dr. Stephen Chanock, Director, Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH Dr. Emily Tonorezos, Director, Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH
8:40–9:45	SESSION I: DATA SHARING Watch this Session
	Moderators: Dr. Kathy Helzlsouer, National Cancer Institute, NIH Dr. Jessica Petrick, Slone Epidemiology Center at Boston University
8:40–9:05	NIH Data Sharing Policy Update Dr. Julia Slutsman, Genomic Data Sharing Policy Implementation, Office of Extramural Research, NIH Dr. Nonye Harvey, Genomic Data Sharing Policy Implementation, Office of Extramural Research, NIH Q & A Session
9:05–9:25	Advances in Data Science from the NIH perspective Dr. Susan Gregurick, Office of Data Science Strategy, NIH Q & A Session
9:25–9:45	Virtual Pooled Registry Cancer Linkage System: Current and Future Initiatives Ms. Castine Clerkin, North American Association of Central Cancer Registries Q & A Session
9:45–10:00	Break
10:00–11:30	SESSION II: CHALLENGES AND OPPORTUNITIES FOR COHORTS OF CANCER SURVIVORS Watch this Session
	Moderators: Dr. Joanne Elena, National Cancer Institute, NIH Dr. Traci Bethea, Georgetown Lombardi Comprehensive Cancer Center
10:00–11:00	Cohort Overview Lymphoma Epidemiology of Outcomes (LEO) Cohort Dr. James Cerhan, Mayo Clinic College of Medicine and Science England & Wales Hodgkin Lymphoma Cohort Dr. Aislinn Macklin-Doherty, The Royal Marsden NHS Foundation Trust ColoCare Consortium (ColoCare) Dr. Neli Ulrich, Comprehensive Cancer Center at Huntsman Cancer Institute Pathways Study Dr. Larry Kushi, Kaiser Permanente Northern California Susan G. Komen Tissue Bank Updates from the Director Dr. Michele Cote, Indiana University Simon Comprehensive Cancer Center
11:00–11:30	Panel Discussion
11:30–11:45	Associate Member Council Update Dr. Lauren E. McCullough, Emory University
11:45	Adjourn
12:00–12:45	Networking Session Hosted by Early Career Scientists (optional)

Day 2, Wednesday, November 2, 2022 (1:00–5:00 p.m. ET)

12:00–12:45	General Networking Session (optional)
1:00–1:05	Watch this Session Opening Remarks Dr. Kathy Helzlsouer, National Cancer Institute, NIH
1:05–1:45	Plenary Session - State of the Science in Survivorship Research Dr. Patricia A. Ganz, UCLA School of Medicine and Public Health and UCLA Jonsson Comprehensive Cancer Center
1:45–2:00	Q & A Session
2:00–3:15	SESSION III: DATA COLLECTION, ACCESS, AND LINKAGES
	Moderators: Dr. Erika Rees-Punia, American Cancer Society Dr. Mia Gaudet, National Cancer Institute, NIH
2:00–2:20	Perspectives on CMS linkage for Cancer Research in Cohort Studies Dr. Lynne R. Wilkens, University of Hawaii Cancer Center Dr. Janet Olson, Mayo Clinic College of Medicine
2:20–2:35	Q & A Session
2:35–3:05	*The All of Us* Research Program- Data Types, Data Access, Data Analysis** Dr. Sheri Schully, All of Us Research Program, NIH
3:05–3:15	Q & A Session
3:15–3:35	Research Facilitation Report Dr. Roger Milne, Cancer Council Victoria
3:35–3:50	Break
3:50–4:50	SESSION IV: COHORT CONSORTIUM PROJECT GROUP REPORT BACKS Watch this Session
	Moderators: Dr. Jeannette Schenk, Fred Hutchinson Cancer Research Center Dr. Melissa Merritt, The University of Sydney Sexual and Gender Minority Interest Group Dr. Sarah S. Jackson, National Cancer Institute, NIH The Breast Cancer Risk Prediction Project Dr. Peter Kraft, Harvard T.H. Chan School of Public Health Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer Dr. Konrad Stopsack, Harvard T.H. Chan School of Public Health Dr. Eboneé Butler, University of North Carolina Lung Cancer Cohort Consortium (LC3) Dr. Mattias Johansson, International Agency for Research Cancer Linkage of NCI Cohort Consortium Projects Dr. Jessica Petrick, Slone Epidemiology Center at Boston University Investigating the role of immune markers in driving sex-specific differences in Glioblastoma (GBM) development Dr. Kristin Waite, National Cancer Institute, NIH
4:50	Closing Remarks and Adjourn Dr. Heather Eliassen, Harvard Medical School and Harvard School of Public Health

Project Group Meetings

There will be an option to register for Project Group meetings at the time of Annual Meeting registration. The Zoom link and additional meeting details for each Project Group meeting session will be sent directly by the Project Group leader to the registered participant.

Date	Name of Project Group	Time
Wednesday, September 14	Physical Activity and Risk of Cancer in the Cohort Consortium	2:30 PM-4:30 PM ET
Thursday, September 22	Prostate Cancer Cohort Consortium (PC3)	10:30 AM-12:30 PM ET
Tuesday, September 27	Ovarian Cancer Cohort Consortium (OC3)	10:30 AM-12:30 PM ET
Thursday, October 6	Impact of Alcohol Use on Cancer Incidence and Mortality	12:30 PM-2:30 PM ET
Tuesday, October 11	AMC- Developing your personal board of directors: mentoring in the National Cancer Institute-Cohort Consortium	10:30 AM-12:30 PM ET
Wednesday, October 12	Premenopausal Breast Cancer Collaborative Group	10:30 AM-12:30 PM ET
Thursday, October 13	Survivorship/Second Cancers Working Group	10:30 AM-12:30 PM ET
Thursday, October 13	Appendiceal Cancer Consortium (APPECC)	12:30 PM-2:30 PM ET
Monday, October 17	Sexual and Gender Minority Interest Group	12:30 PM-2:30 PM ET
Tuesday, October 18	PanScan	1:00 PM-3:30 PM ET
Wednesday, October 19	Alcohol, Diet and Body Fatness as Risk Factors for Stomach Cancer and its Subtypes	2:30 PM-4:30 PM ET
Thursday, October 20	Breast Cancer Risk Prediction Modeling Working Group	10:30 AM-12:30 PM ET
Thursday, October 20	Pooling Project of Prospective Studies of Diet and Cancer (DCCP) (includes the Family History and Cancer Risk and Mortality Project Group)	2:30 PM-4:30 PM ET
Monday, October 24	Design and validation of an oral cancer risk prediction model	10:30 AM-12:30 PM ET
Tuesday, October 25	Cancer in Hispanic Populations Working Group	10:30 AM-12:30 PM ET
~~Wednesday, October 26~~	~~Lung Cancer Cohort Consortium (LC3)~~ *The meeting has been rescheduled to a later date, more information will be coming soon.*	~~10:30 AM-12:30 PM ET~~
~~Thursday, October 27~~	~~Diabetes and Cancer Initiative in the Cohort Consortium~~ *The meeting has been rescheduled to a later date, more information will be coming soon.*	~~10:30 AM-12:30 PM ET~~
~~Monday, October 31~~	~~Coffee Drinking and Mortality~~ *The meeting has been rescheduled to a later date, more information will be coming soon.*	~~10:30 AM-12:30 PM ET~~

Meeting Materials

Scientific Abstracts and Graphical Slides

Scientific abstracts and graphical slides related to scientific work done as part of consortium activities